ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Systematic Review
Revised

Peruvian contributions to scientific publications on experimental research against COVID-19: a systematic review

[version 2; peer review: 1 approved, 1 approved with reservations]
* Equal contributors
PUBLISHED 25 Sep 2023
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Research on Research, Policy & Culture gateway.

This article is included in the Coronavirus collection.

Abstract

Background: One of the countries most adversely affected by the COVID-19 outbreak was Peru. Worldwide scientific knowledge creation has significantly grown because of this pandemic. This systematic study aims to examine several facets of Peru's experimental scientific production concerning COVID-19.
Methods: Between December 2019 and June 2022, searches were made in the PubMed database for experimental scientific articles created in Peruvian institutions. Data were extracted and analyzed on the type of biomedical research, the study's applicability, the thematic area and specific thematic, journal impact factor and quartile, funding, grants, and institution of affiliation for the first and correspondence authors.
Results: The systematic review resulted in nine studies that met the requirements. The results revealed that Peru needs to promote policies to boost research funding and the number of researchers to produce information that will be useful for managing diseases in the future. Yet, despite the funding provided by national organizations like National Council for Science, Technology, and Technological Innovation (CONCYTEC), there were few publications and little international collaboration. The studies that have been published focus mostly on applied research in the areas of diagnostics, sanitary products, and treatment and transmission, and they have great visibility because they are indexed in Q1 journals.
Conclusions: This thorough study revealed Peru's inadequate reaction to COVID-19 regarding experimental scientific research. Peruvian authorities should think about supporting the required policies to boost the number of researchers and financial aid to produce information that may be utilized to manage potential new diseases in the future.
Inplasy registration: INPLASY202340080 (23/04/2023).

Keywords

bibliometrics, COVID-19, Peru, systematic review, publications, statistics, numerical data, research

Revised Amendments from Version 1

For this version of the paper, the first reviewer's observations were considered. In the methods section of the manuscript, a more thorough explanation of the methodology used to choose the paper reviewed in the systematic review was added, while the introduction section of the manuscript received clarifications addressing the One Health definition. Additionally, a paragraph outlining the limitations of the study was added to the discussion section.

See the authors' detailed response to the review by Christopher J Peterson

Abbreviations

The following abbreviations are used in this study

CONCYTEC

National Council for Science, Technology, and Technological Innovation

COVID-19

Coronavirus disease

FARVET SAC

Farmacológicos Veterinarios SAC

FONDECYT

National Funding for Scientific and Technological Development

INPLASY

International Platform of Registered Systematic Review and Meta-analysis Protocols

INS

National Health Institute

MeSH

Medical Subject Headings

NCBI

National Center for Biotechnology Information

NML

National Library of Medicine

PMC

PubMed Central

PMID

PubMed Identifier

PRISMA

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

RENACYT

National Scientific, Technological and Technological Innovation Registry

SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2

Introduction

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in December 2019 in Wuhan, China, and has spread worldwide, becoming a pandemic with catastrophic effects.13 SARS-CoV-2 severely affects humans because it is highly transmissible and rapidly mutates4 and is reported to have a mortality rate between 0.8–19.6% with regional variation.4,5 Various health strategies have been applied around the world, such as non-pharmacological interventions (use of masks, social distancing, monitoring of infected persons, etc.) and vaccination to reduce the spread of the virus and contagion.6 However, since the emergence of SARS-CoV-2, there have been approximately 755 million cases of COVID-19 and 6.8 million deaths up to February 2023 (https://covid19.who.int/).

The first case of COVID-19 in Peru was reported on March 6, 2020, and community transmission began on March 17, 2020. At the beginning of the pandemic, the Peruvian government determined prevention measures and mandatory social isolation to control the spread of SARS-CoV-2.7,8 However, it could not avoid being one of the countries most affected in the number of cases, deaths per million, and total excess samples during the COVID-19 pandemic.9,10 In the first half of 2021, the Lambda variant of SARS-CoV-2 became the most predominant variant in Peru’s Coastal and Andean regions, while Gamma predominated in the Amazon.11 In February 2023, the Ministry of Health of Peru reported 4.4 million positive cases and 219, 269 deaths.

Faced with the current health crisis due to the COVID-19 pandemic, there has been an increase in scientific production on the subject worldwide in different fields due to the need to effectively control the disease (finding health solutions, treatments, diagnostic methods, understanding the pathophysiology of the virus, research into vaccines, etc.).12,13 As a result, the Peruvian government issued a supreme decree to encourage clinical trials on the prevention, diagnosis, and treatment of COVID-19.14,15 Additionally, the National Council for Science, Technology, and Technological Innovation (CONCYTEC), called for funding for research.16

One Health is a holistic approach that recognizes the interconnectedness of human health, animal health, and the health of the environment.14,15,17 It emphasizes the interdependence between these three domains and aims to address health issues and challenges by considering the interactions and impacts that occur at the intersection of human, animal, and environmental health.18 The COVID-19 pandemic has shown the importance of worldwide cooperation in developing and distributing vaccines and treatments and exchanging knowledge and resources.19 Additionally, scientists from several fields, including epidemiology, virology, animal health, and environmental health, collaborate as part of the One Health concept.14 Thus, various countries have carried out an internal investigation to respond to their own needs regarding COVID-19 according to their capacities and infrastructure.15,16,20,21 Therefore, the objective of this research is to evaluate the generation capacity of experimental research carried out in Peru, which will help in making future decisions, both to establish future studies, to elucidate the lack of studies in certain areas, as well as to determine the country’s roadmap in a current and future state of emergency.

Methods

Study protocol

The present systematic review was carried out as per the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).22 The protocol for this systematic review was registered on INPLASY (INPLASY202340080) and is available in full at inplasy.com. The systematic review has been elaborated according to PRISMA 2020 checklist (see Reporting guidelines).22

Search strategy

The search was limited to studies published from December 2019 to June 22, 2022, in the PubMed database (Last accessed on 22 June 2022), with free electronic access that contains more than 35 million citations and abstracts of biomedical literature that includes various literature resources of the National Library of Medicine (NML) such as MEDLINE, PMC, and other databases.23 The search for the terms associated in the literature with COVID-19 and Peru was carried out using the MeSH term (Medical Subject Heading), and the results were analyzed in a co-occurrence network map of MeSH terms in the VOSviewer software (version 1.6.18).24 MeSH terms, which are used to index the citations since this is a vocabulary controlled by the NML, organize their descriptors hierarchically so that more specific articles can be found from a broad search. Specialists from various areas constantly update the MESH term; every year, new concepts are modified and added.25,26 The search string used in PubMed was: ((COVID-19[MeSH Terms]) OR (SARS-CoV-2 [MeSH Terms])) AND (PERU).

Selection criteria and data extraction

The studies included in the systematic review were selected in three stages. First, duplicate articles, original articles other than the English language, critical and systematic reviews, meta-analyses, and publications other than an original article were excluded: letters to the editor, commentary, editorial and case reports, data studies, news, conference, and directory; all these classifications were considered using the PubMed filters.2729 Secondly, the titles and abstracts of the studies selected using the search strategy were analyzed. Finally, complete papers that might be relevant were located and separated from journals whose titles or abstracts lacked the pertinent information to be taken into account in the systematic review. The included studies were those that were published in journals of quartile one or two, had first authors and/or corresponding authors with Peruvian institutional affiliations, and/or had Peruvian funding. The research topics for these studies had to produce new scientific knowledge, development, innovation, and/or adaptation of new or improved low-cost technologies, products, mechanisms, or services.30,31

Data extraction was performed by K.C.-M. and validated independently by M.A.C.-P., with discrepancies resolved through discussion and by conferring with M.A.C.-F. The following data were extracted: first author, first author’s institution of affiliation, first author’s country, corresponding author, corresponding author’s affiliation, corresponding author’s country, journal, year of publication, quartile, impact factor, institution funder, research topic, type of biomedical research, and study applicability. The quartiles and impact factors of the journals were obtained from the Scimago Journal and Country Rank and/or on the main pages of each journal, respectively. The classification by type of biomedical research was carried out considering basic research (animal experiments, cellular studies, biochemical, genetic, and physiological research, and studies on the properties of drugs and materials) and applied research or clinical studies (interventional studies (or experimental) and non-interventional (or observational), criteria established by Röhrig, B. et al. 2009.32 Furthermore, according to the applicability of the study, they were classified into two types of research: basic and applied. Basic research aims to explain phenomena by obtaining information and applied research seeks to provide a concrete practical application, that is, to solve a specific problem. These criteria were taken from CONCYTEC of Peru.

Results

Data sources and study selection

A thorough analysis of Peru’s experimental scientific research on COVID-19 was carried out in the current paper. The study strategy’s flowchart was created and displayed (Figure 1). To do this, a search was conducted in the PubMed database using the search mentioned above string of MeSH terms, and a network map of the co-occurrence of MeSH terms was created (Figure 2). Through the search, 794 scientific papers between December 2019 and June 22, 2022, were found. A network map was created using 2,390 keywords, of which 212 achieved thresholds, and the minimum number of keyword occurrences was set at five. The most frequently occurring keywords were “COVID-19” (935 occurrences; total link strength: 7,327) and “HUMANS” (788 occurrences). The size of the nodes shows how frequently they occur. The co-occurrence of the nodes is shown by the curves connecting them in the same publication. The frequency of co-occurrences of two keywords increases with decreasing distance between nodes; in this case, the most frequent terms, such as “COVID-19”, “HUMANS”, “SARS-COV-2”, “PANDEMICS”, and “PERU”, are observed (Figure 2). Nine studies on experimental scientific research on COVID-19 were selected (Figure 1). Data such as PMID, research types, the applicability of the study, theme, specific theme, year, and journal were taken out of the chosen studies (Table 1).

c56859b0-6bbe-45e2-b61b-bb4e4e9a0ff8_figure1.gif

Figure 1. Systematic review Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of the study selection process.

c56859b0-6bbe-45e2-b61b-bb4e4e9a0ff8_figure2.gif

Figure 2. Selected articles using the PubMed database relating to COVID-19 and Peru.

A) Network map built by VOSviewer based on the co-occurrence of MeSH terms. B) Red cluster zoom related to COVID-19 and Peru. C) Word cloud based on the Keywords.

Table 1. Studies on Peruvian experimental scientific research on COVID-19.

PMIDTypes of Biomedical ResearchStudy applicabilityThematic areaSpecific thematicYearJournal
3376087640Clinical observation diagnosisAppliedDiagnosticRapid diagnostic methodologies2021PLOS One
3391354235BasicBasicTreatment and transmissionStudies of the transmission mechanisms of the virus to reduce its spread2021Journal of Medical Virology
3426813141Clinical observation diagnosisAppliedDiagnosticLaboratory tests2021Frontiers in Cellular & Infection Microbiology
3432642936BasicAppliedTreatment and transmissionStudies of molecules and their possible application for SARS-CoV-22021Scientific Reports
3420209237BasicAppliedTreatment and transmissionStudies of molecules and their possible application for SARS-CoV-22021Molecules
3476893938BasicBasicTreatment and transmissionStudies of the transmission mechanisms of the virus to reduce its spread2021International Journal of Molecular Sciences
3493093342Clinical observation diagnosisAppliedDiagnosticDiagnostic test adaptations2021Scientific Reports
3523974043Experimental clinical (preclinical study)AppliedSanitary AccessoriesMechanical ventilation2022PLoS One
3566400839BasicAppliedTreatment and transmissionStudies of molecules and their possible application for SARS-CoV-22022Frontiers in Immunology

Type of biomedical research and study applicability

Biomedical research generally encompasses basic and clinical research also called applied research, specifically observational diagnostic studies and experimental studies.33,34 The basic biomedical research category, comprising 55.6% (n = 5)3539 of the total studies considered in the review, came in first position as the category with the most original publications. On the other hand, clinical observation diagnoses accounted for 44.4 % (n = 4)4043 of the total number of original articles and was the second type of biomedical research with the highest number of unique publications. Of these, 11.1% (n = 1) of the total original articles of the review were classified as “Experimental” clinical research, specifically a preclinical study, and 33.3% (n = 3) of the total original articles of the review were classified as “Diagnostic Observational” clinical research (Table 1).

Two categories of research—basic and applied—were separated based on inquiry. Basic research seeks to understand phenomena by gathering data, whereas applied research’s major goal is to provide an accurate, practical application, or to address a particular issue.30,31 The systematic review results were classified according to their applicability, of which the most prevalent was “Applied” research with 77.8% (n = 7) of the total original articles of the review. On the other hand, the one with the lowest prevalence was “Basic” research with 22.2% (n = 2) of the total original articles of the systematic review (Table 1).

Thematic area and specific thematic

The calls for funding, “Special Projects: Response to COVID-19” and “Special Projects: Modality Emerging Needs to COVID-19 2020-02,” both sponsored by CONCYTEC in response to the national emergency of COVID-19, were used to trace general and specific categories for the studies of the systematic review.30,31 The first place was taken by the thematic area of “Treatment and transmission,” which accounted for 55.6% (n = 5) of the total original articles. The second place went to the thematic area of “Diagnosis,” which accounted for 33.3% (n = 3) of the total studies, while the third and final place went to the thematic area of “Sanitary accessories,” which accounted for 11.1% (n = 1) of the total studies. Study of molecules and potential applications for SARS-CoV-2 was the specific theme that predominated, accounting for 33.3% (n = 3) of all original articles, followed by “Studies of virus transmission mechanisms to reduce its spread,” accounting for 22.2% (n = 2) of original articles. Both specific themes fall under the treatment and transmission thematic area. However, “Diagnosis” was the next most prevalent theme, with “Adaptations of diagnostic tests” accounting for 11.1% (n = 1) of the total number of original articles, “Rapid diagnosis methodology” coming in second with 11.1% (n = 1), and “Tests laboratory” coming in third with 11.1% (n = 1) of the total number of original articles (Table 1). Finally, the specific theme with the lowest number of original articles was “Sanitary accessories”, having only one specific subject and one original article “Respirators and ventilators” with 11.1% (n = 1) of the total original articles of the review (Table 1).

Journal impact factor and quartile

A first quartile (Q1) journal has a high impact factor and number of citations in a specific thematic area, allowing greater visibility of published articles.44,45 The authors managed to publish in Scientific Reports and PLOS One most often (n = 2; 22.2%), whereas only one original paper (11.1%) was published in each of the other five journals. One journal from the United Kingdom, two from the United States, and four from Switzerland made up the total number of journals in the systematic review research. Seven journals came from the first quartile (Q1). The highest impact factors were 20.693, 6.429, and 6.208, representing the Journal of Medical Virology, Frontiers in Immunology, and International Journal of Molecular Sciences in first, second, and third position, respectively. The fourth- and fifth-placed journals were Scientific Reports with an impact factor of 4,996 and Molecules with 4,927. Finally, Frontiers in Cellular and Infection Microbiology and PLOS One impact factors of 4,300 and 3.240, respectively, were sixth and seventh in the ranking as the journals with the highest impact factor (Table 2).

Table 2. Journal impact factor and quartile of the systematic review studies.

JournalCountryImpact FactorQuartilen
1PLOS OneEEUU3.24012
2Scientific ReportsUnited Kingdom4.99612
3Frontiers in ImmunologySwitzerland6.42911
4Frontiers in Cellular and Infection MicrobiologySwitzerland4.30011
5Journal of Medical VirologyEEUU20.69311
6International Journal of Molecular SciencesSwitzerland6.20811
7MoleculesSwitzerland4.92711
Total9

Funding and grants

Only one (11.1%) of the included articles was jointly funded by Peru and the United States. The organizations that funded the most original articles were the National Health Institute (INS), CONCYTEC, and Universidad Católica de Santa Maria representing 22.2% (n = 2) of total included articles. The country that financed the largest number of original studies was Peru, with 88.9% (n = 8) of the total articles. Co-financing for one study (11.1%) in the systematic review came from INS and CONCYTEC, “Universidad Católica de Santa Mara” and “US Grants” jointly funded one study (11.1%) and CONCYTEC and Universidad San Juan Bautista jointly funded one study (11.1%). Only two universities in Peru—Universidad Católica de Santa Mara and Universidad San Juan Bautista—funded articles included in the systematic review (Table 3).

Table 3. Funds and grants of the systematic review studies.

RankingFinancing Institutionsn
1National Institute of Health (INS) - Perú2
2National Funding for Scientific and Technological Development (FONDECYT)2
3Universidad Católica de Santa María2
4National Institute of Health and FONDECYT1
5CONCYTEC and Universidad San Juan Bautista1
6Grant from U.S.A. and Universidad Católica de Santa María1
Total9

Affiliation of the first author

Meanwhile, Universidad Católica de Santa Mara, Universidad Cayetano Heredia, and FARVET SAC are tied for second position with 22.2% each (n = 2). The institutions with the lowest production of original papers from the included studies were Harvard Medical School, Massachusetts General Hospital, and Pontificia Universidad Católica del Peru, all of which produced 11.11% (n = 1) of all the systematic review’s original publications (Table 4). Regarding the institution with the highest production of original articles of the systematic review based on the affiliation of the first author. Universidad Católica de Santa María and INS occupy the first place, each with 33.3% (n = 3), followed by the Universidad Peruana Cayetano Heredia, Pontificia Universidad Católica del Perú and Farmacológicos Veterinarios SAC (FARVET SAC), all of them with 11.1% (n = 1). The results showed that all the original articles produced by the “Universidad Católica de Santa María” (n = 3) belonged to the thematic “Treatment and transmission”. Similarly, “Diagnosis” was the theme shared by all the original papers produced by INS (n = 3). Universidad Peruana Cayetano Heredia and FARVET SAC, on the other hand, both published articles on the “Treatment and transmission” theme. Finally, Pontificia Universidad Católica del Peru published an article with the theme “Sanitary accessories”. Based on the affiliation of the first author, Lima, Peru, produced the most original articles, accounting for 55.6% (n = 5) of the total; Arequipa, Peru, produced 33.3% (n = 3) of the total; and the city of Cusco, Peru produced the least original articles. The city of Chincha accounted for 11.1% (n = 1) of all originals (Table 5).

Table 4. Classification of the affiliation, city, and theme of the first author.

InstitutionCity and CountrynThematic
Universidad Católica de Santa MaríaArequipa, Perú3Treatment and transmission
INSLima, Perú3Diagnostic
Universidad Peruana Cayetano HerediaLima, Perú1Treatment and transmission
Pontificia Universidad Católica del PerúLima, Perú1Sanitary accessories
FARVET SACChincha, Perú1Treatment and transmission
Total9

Table 5. Classification of the affiliation and city of the corresponding author.

Institutionn% StudiesCityCountry
INS222.2%LimaPeru
INS and Universidad Privada San Juan Bautista111.1%LimaPeru
Pontificia Universidad Católica del Perú111.1%LimaPeru
Universidad Peruana Cayetano Heredia and FARVET SAC222.2%Lima and ChinchaPeru
Universidad Católica de Santa María222.2%ArequipaPeru
Massachusetts General Hospital and Harvard Medical School111.1%BostonUnited States
Total9

Affiliation of the correspondence author

Most of the corresponding authors of the included articles were affiliated in “Peru”, accounting for 88.9% (n = 8) of the total. The United States was second with 11.1% (n = 1). The city of Lima accounted for 44.4% (n = 5) of the corresponding authors’ affiliations in Peru, followed by Arequipa and Chincha with 22.2% (n = 2) each. Most corresponding authors were affiliated with INS (33.3%; n = 3). Two of these articles list INS as the sole affiliation of the corresponding author, while the third includes both INS and Universidad San Juan Bautista. The Universidad Católica de Santa Maria, Universidad Cayetano Heredia, and FARVET SAC, each had two corresponding authors (22%; n = 2). Finally, Harvard Medical School, Massachusetts General Hospital, and Pontificia Universidad Católica del Peru are the organizations that produced the fewest included articles in the systematic review, accounting for a combined 11.11% (n = 1) of all the systematic review’s articles (Table 5).

Discussion

Scientific research plays a significant role in preventing and controlling pathogens, such as SARS-CoV-2, which can cause pandemics, so it must be strengthened and increased to have a better response against future pathogens.46,47 There was a sharp rise in the number of scientific papers on the COVID-19 pandemic because of the numerous investigations that researchers carried out around the world.16,48 For this reason, this systematic review summarizes the experimental scientific research carried out in Peru against COVID-19 to identify and analyze trends and gaps in the experimental scientific field to guide the priorities and actions of researchers in future studies.

Peru was one of the countries most affected by COVID-19,49,50 not only because of the vast death toll51,52 but also because of the country’s economy.53 Nonetheless, until 2021, Peru had allocated around 2.9 million US dollars to 50 projects to conduct scientific research related to COVID-19.54 However, as reported in this systematic review, the production of original experimental articles was deficient, since only nine studies were found to have originated in Peru, of which six were executed with government funds. This number, as mentioned, is extremely modest considering that there was an average of 137 study articles published every day in the months immediately after the virus emerged. This demonstrates how productive research groups throughout the world were.51,55 Insufficient laboratory infrastructure and funding, a lack of professional security for scientists, a lack of policies to direct scientific projects, and political corruption contribute to low scientific productivity in developing nations like Peru.52,53,56

Applied research made up 78% of the studies examined. In contrast to basic research, which aims to understand how nature functions without any other practical incentive, applied research focuses on using current knowledge to address a specific need.57 Since applied research stresses the quick resolution of specific population problems, it is recommended that developing nations focus their investment efforts there.40 Peru will continue to follow this pattern as long as the country lacks the resources to conduct basic and novel research. A developing nation is thought to benefit from focusing its investment efforts on applied research since it stresses the quick resolution of issues that impact the populace.56 RENACYT is the National Scientific, Technological, and Technological Innovation Registry of natural persons, Peruvian or foreign, who carry out science, technology, and innovation activities in Peru. According to the regulations established in 2021, Peru had 4,702 active researchers in February 2023 (https://servicio-renacyt.concytec.gob.pe/). Accordingly, there were 147 researchers for every million people, of whom 31% were researchers in the health sciences. This ratio is lower than that of other South American nations like Chile, Colombia, and Mexico, where there are 400 researchers for every million people.37 Peru’s weak scientific output is directly tied to the country’s low researcher population.

Recent decades have seen a rise in the importance of scientific collaboration, which is more effective than individual work and increases the possibility of publishing in high-impact journals through collaborative research.53,58 Considering the affiliation of the first author and that of the corresponding author of the included studies that form part of this review, only one presented an international collaboration between the University of Peru and a US institution.38 Given that international collaborations have a stronger beneficial impact than national, local or intra-university ones, Peru should boost its cooperation to increase research productivity.59

The small number of publications that were included in this study is a serious limitation that should be taken into account. The scope and depth of the analysis are inevitably constrained because there are only a total of 11 papers included. This choice restricts the thorough investigation of the topic matter while also demonstrating the strict commitment to the requirements. With such a limited dataset, the complex variations and nuances within the issue might not be properly reflected. Due to the small sample size, it is advised to proceed with caution when interpreting the study’s findings and conclusions because they may not accurately reflect the subject’s wider context. Despite the researchers’ rigorous approach to data gathering and analysis, it is necessary to highlight the inherent restriction of the small number of publications because it affects the generalizability and robustness of the study’s findings.

Conclusions

Peru is one of the countries that has funded the growth of experimental research related to COVID-19. Still, as this study indicates, there has been low publication output compared to scientific production worldwide, despite having a financial incentive, and there was very little international collaboration in these papers. Despite the low scientific productivity in Peru, the researchers who wrote the publications reported their findings in high-impact journals. As a result, Peru should support appropriate policies to increase the number of researchers and financial support to allow research to be published for the benefit of its citizens and to better prepare for pandemics like COVID-19 in the future.

Comments on this article Comments (1)

Version 3
VERSION 3 PUBLISHED 14 Nov 2023
Revised
Version 2
VERSION 2 PUBLISHED 25 Sep 2023
Revised
Discussion is closed on this version, please comment on the latest version above.
  • Author Response 28 Nov 2023
    Miguel Angel Chavez-Fumagalli, Computational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Catolica de Santa Maria de Arequipa, Arequipa, 04000, Peru
    28 Nov 2023
    Author Response
    Comments:
    The authors offer an original and contemporary perspective on Peruvian contributions to scientific publications on experimental research against COVID-19. As applied research stresses the quick resolution of specific population ... Continue reading
  • Discussion is closed on this version, please comment on the latest version above.
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Coronel-Monje K, Candia-Puma MA, Vilca-Alosilla JJ et al. Peruvian contributions to scientific publications on experimental research against COVID-19: a systematic review [version 2; peer review: 1 approved, 1 approved with reservations] F1000Research 2023, 12:875 (https://doi.org/10.12688/f1000research.134989.2)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 2
VERSION 2
PUBLISHED 25 Sep 2023
Revised
Views
7
Cite
Reviewer Report 27 Oct 2023
Somipam R. Shimray, Babasaheb Bhimrao Ambedkar University, Lucknow, India 
Approved
VIEWS 7
Comments:
The authors offer an original and contemporary perspective on Peruvian contributions to scientific publications on experimental research against COVID-19. As applied research stresses the quick resolution of specific population problems, this study calls for developing nations to invest ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Shimray SR. Reviewer Report For: Peruvian contributions to scientific publications on experimental research against COVID-19: a systematic review [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research 2023, 12:875 (https://doi.org/10.5256/f1000research.156276.r214605)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 1
VERSION 1
PUBLISHED 24 Jul 2023
Views
21
Cite
Reviewer Report 25 Aug 2023
Christopher J Peterson, Virginia Tech Carilion School of Medicine, Roanoke, USA 
Approved with Reservations
VIEWS 21
The authors present a unique perspective on research and academic publishing during the COVID-19 pandemic, namely from the perspective of a developing country. This work doesn’t merely recognize the limitations that such a country might face on the global research ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Peterson CJ. Reviewer Report For: Peruvian contributions to scientific publications on experimental research against COVID-19: a systematic review [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research 2023, 12:875 (https://doi.org/10.5256/f1000research.148087.r196201)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 06 Oct 2023
    Miguel Angel Chavez-Fumagalli, Computational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Catolica de Santa Maria de Arequipa, Arequipa, 04000, Peru
    06 Oct 2023
    Author Response
    The authors present a unique perspective on research and academic publishing during the COVID-19 pandemic, namely from the perspective of a developing country. This work doesn’t merely recognize the limitations ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 06 Oct 2023
    Miguel Angel Chavez-Fumagalli, Computational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Catolica de Santa Maria de Arequipa, Arequipa, 04000, Peru
    06 Oct 2023
    Author Response
    The authors present a unique perspective on research and academic publishing during the COVID-19 pandemic, namely from the perspective of a developing country. This work doesn’t merely recognize the limitations ... Continue reading

Comments on this article Comments (1)

Version 3
VERSION 3 PUBLISHED 14 Nov 2023
Revised
Version 2
VERSION 2 PUBLISHED 25 Sep 2023
Revised
Discussion is closed on this version, please comment on the latest version above.
  • Author Response 28 Nov 2023
    Miguel Angel Chavez-Fumagalli, Computational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Catolica de Santa Maria de Arequipa, Arequipa, 04000, Peru
    28 Nov 2023
    Author Response
    Comments:
    The authors offer an original and contemporary perspective on Peruvian contributions to scientific publications on experimental research against COVID-19. As applied research stresses the quick resolution of specific population ... Continue reading
  • Discussion is closed on this version, please comment on the latest version above.
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.